Follow
Andrew H. Wei
Andrew H. Wei
Peter MacCallum Cancer Centre, Royal Melbourne Hospital and Walter and Eliza Hall Institute of
No verified email
Title
Cited by
Cited by
Year
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
H Döhner, E Estey, D Grimwade, S Amadori, FR Appelbaum, T Büchner, ...
Blood, The Journal of the American Society of Hematology 129 (4), 424-447, 2017
56482017
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
L Chen, SN Willis, A Wei, BJ Smith, JI Fletcher, MG Hinds, PM Colman, ...
Molecular cell 17 (3), 393-403, 2005
22362005
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ...
New England Journal of Medicine 377 (5), 454-464, 2017
20972017
Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia
H Kantarjian, A Stein, N Gökbuget, AK Fielding, AC Schuh, JM Ribera, ...
New England Journal of Medicine 376 (9), 836-847, 2017
17642017
Azacitidine and venetoclax in previously untreated acute myeloid leukemia
CD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ...
New England Journal of Medicine 383 (7), 617-629, 2020
17382020
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
CD DiNardo, K Pratz, V Pullarkat, BA Jonas, M Arellano, PS Becker, ...
Blood, The Journal of the American Society of Hematology 133 (1), 7-17, 2019
15932019
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
SN Willis, L Chen, G Dewson, A Wei, E Naik, JI Fletcher, JM Adams, ...
Genes & development 19 (11), 1294-1305, 2005
15742005
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
MF Van Delft, AH Wei, KD Mason, CJ Vandenberg, L Chen, PE Czabotar, ...
Cancer cell 10 (5), 389-399, 2006
14552006
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ...
Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022
10202022
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
A Kotschy, Z Szlavik, J Murray, J Davidson, AL Maragno, ...
Nature 538 (7626), 477-482, 2016
9822016
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
H Döhner, AH Wei, FR Appelbaum, C Craddock, CD DiNardo, H Dombret, ...
Blood, The Journal of the American Society of Hematology 140 (12), 1345-1377, 2022
9752022
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label …
CD DiNardo, KW Pratz, A Letai, BA Jonas, AH Wei, M Thirman, ...
The lancet oncology 19 (2), 216-228, 2018
6852018
Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: results from a phase Ib/II study
AH Wei, SA Strickland Jr, JZ Hou, W Fiedler, TL Lin, RB Walter, A Enjeti, ...
Journal of Clinical Oncology 37 (15), 1277, 2019
6282019
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
AH Wei, P Montesinos, V Ivanov, CD DiNardo, J Novak, K Laribi, I Kim, ...
Blood, The Journal of the American Society of Hematology 135 (24), 2137-2145, 2020
5772020
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
CD DiNardo, IS Tiong, A Quaglieri, S MacRaild, S Loghavi, FC Brown, ...
Blood, The Journal of the American Society of Hematology 135 (11), 791-803, 2020
4602020
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
SP Glaser, EF Lee, E Trounson, P Bouillet, A Wei, WD Fairlie, DJ Izon, ...
Genes & development 26 (2), 120-125, 2012
4552012
AMG 176, a selective MCL1 inhibitor, is effective in hematologic cancer models alone and in combination with established therapies
S Caenepeel, SP Brown, B Belmontes, G Moody, KS Keegan, D Chui, ...
Cancer discovery 8 (12), 1582-1597, 2018
3572018
Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission
AH Wei, H Döhner, C Pocock, P Montesinos, B Afanasyev, H Dombret, ...
New England Journal of Medicine 383 (26), 2526-2537, 2020
3202020
BH3-mimetic drugs: blazing the trail for new cancer medicines
D Merino, GL Kelly, G Lessene, AH Wei, AW Roberts, A Strasser
Cancer cell 34 (6), 879-891, 2018
2902018
Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML
D Duarte, ED Hawkins, O Akinduro, H Ang, K De Filippo, IY Kong, ...
Cell stem cell 22 (1), 64-77. e6, 2018
2852018
The system can't perform the operation now. Try again later.
Articles 1–20